Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial (vol 11, pg 611, 2009)

被引:0
|
作者
Jadzinsky, M.
Pfuetzner, A.
Paz-Pacheco, F.
Xu, Z.
Allen, F.
Chen, R.
机构
来源
DIABETES OBESITY & METABOLISM | 2010年 / 12卷 / 05期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:462 / 462
页数:1
相关论文
共 50 条
  • [31] Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial
    Del Prato, S.
    Barnett, A. H.
    Huisman, H.
    Neubacher, D.
    Woerle, H. -J.
    Dugi, K. A.
    DIABETES OBESITY & METABOLISM, 2011, 13 (03): : 258 - 267
  • [32] Initial combination therapy with sitagliptin and pioglitazone improves glycaemic control and measures of beta cell function compared with pioglitazone alone in patients with type 2 diabetes
    Yoon, K.
    Shockey, G.
    Teng, R.
    Golm, G.
    Thakkar, P.
    Meehan, A.
    Williams-Herman, D.
    Kaufman, K.
    Amatruda, J.
    Steinberg, H.
    DIABETOLOGIA, 2009, 52 : S294 - S294
  • [33] Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
    Rosenstock, Julio
    Hansen, Lars
    Zee, Pamela
    Li, Yan
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    DIABETES CARE, 2015, 38 (03) : 376 - 383
  • [34] Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
    Lee, Jie-Eun
    Yu, Seung Hee
    Kim, Sung Rae
    Ahn, Kyu Jeung
    Song, Kee-Ho
    Lee, In-Kyu
    Shon, Ho-Sang
    Kim, In Joo
    Lim, Soo
    Kim, Doo-Man
    Chung, Choon Hee
    Lee, Won-Young
    Lee, Soon Hee
    Kim, Dong Joon
    Cho, Sung-Rae
    Jung, Chang Hee
    Jeon, Hyun Jeong
    Lee, Seung-Hwan
    Park, Keun-Young
    Rhee, Sang Youl
    Kim, Sin Gon
    Park, Seok O.
    Kim, Dae Jung
    Kim, Byung Joon
    Lee, Sang Ah
    Kim, Yong-Hyun
    Kim, Kyung-Soo
    Seo, Ji A.
    Nam-Goong, Il Seong
    Lee, Chang Won
    Kim, Duk Kyu
    Kim, Sang Wook
    Cho, Chung Gu
    Kim, Jung Han
    Kim, Yeo-Joo
    Yoo, Jae-Myung
    Min, Kyung Wan
    Lee, Moon-Kyu
    ACTA PEDIATRICA DE MEXICO, 2024, 48 (04):
  • [35] Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
    Lee, Jie-Eun
    Yu, Seung Hee
    Kim, Sung Rae
    Ahn, Kyu Jeung
    Song, Kee-Ho
    Lee, In-Kyu
    Shon, Ho-Sang
    Kim, In Joo
    Lim, Soo
    Kim, Doo-Man
    Chung, Choon Hee
    Lee, Won-Young
    Lee, Soon Hee
    Kim, Dong Joon
    Cho, Sung-Rae
    Jung, Chang Hee
    Jeon, Hyun Jeong
    Lee, Seung-Hwan
    Park, Keun-Young
    Rhee, Sang Youl
    Kim, Sin Gon
    Park, Seok O.
    Kim, Dae Jung
    Kim, Byung Joon
    Lee, Sang Ah
    Kim, Yong-Hyun
    Kim, Kyung-Soo
    Seo, Ji A.
    Nam-Goong, Il Seong
    Lee, Chang Won
    Kim, Duk Kyu
    Kim, Sang Wook
    Cho, Chung Gu
    Kim, Jung Han
    Kim, Yeo-Joo
    Yoo, Jae-Myung
    Min, Kyung Wan
    Lee, Moon-Kyu
    DIABETES & METABOLISM JOURNAL, 2024, 48 (04) : 730 - 739
  • [36] Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial
    Umpierrez, Guillermo
    Issa, Maher
    Vlajnic, Aleksandra
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (04) : 751 - 759
  • [37] Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial
    Hulst, A. H.
    Polderman, J. A. W.
    Ouweneel, E.
    Pijl, A. J.
    Hollmann, M. W.
    DeVries, J. H.
    Preckel, B.
    Hermanides, J.
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 749 - 752
  • [38] Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study
    Patel, J
    Anderson, RJ
    Rappaport, EB
    DIABETES OBESITY & METABOLISM, 1999, 1 (03): : 165 - 172
  • [39] The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin
    Tong, PC
    Chow, CC
    Jorgensen, LN
    Cockram, CS
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (02) : 93 - 98
  • [40] A randomized controlled clinical trial of combination therapy for type 2 diabetes by vildagliptin, metformin, and α-glucosidase inhibitor
    Qiong Wang
    Yong Su
    Lifang Lv
    International Journal of Diabetes in Developing Countries, 2016, 36 : 420 - 425